We examined risk of newly detected human papillomavirus ( HPV ) infection and cervical abnormalities in relation to HPV type 16/18 antibody levels at enrollment in PATRICIA ( Papilloma Trial Against Cancer in Young Adults ; NCT00122681 ) .